Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RIPK1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of RIPK1 mRNA | increases expression | 18648102
|
D002108 |
Caerulein |
Caerulein results in increased cleavage of RIPK1 protein | increases cleavage | 16339139
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of RIPK1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK1 mRNA | affects cotreatment|increases expression | 17942748
|
D005665 |
Furosemide |
Furosemide affects the expression of RIPK1 mRNA | affects expression | 17497460
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA | affects cotreatment|increases expression | 17183730
|
C013592 |
mangiferin |
mangiferin results in decreased expression of RIPK1 mRNA | decreases expression | 15135318
|
D015058 |
1-Naphthylisothiocyanate |
1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA | increases expression | 15913567
|
D015058 |
1-Naphthylisothiocyanate |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA] | decreases reaction|increases expression | 15913567
|
C107010 |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA] | decreases reaction|increases expression | 15913567
|
C059514 |
resveratrol |
resveratrol analog results in decreased expression of RIPK1 protein | decreases expression | 15652768
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA | increases expression | 15328365 12167310 15800033
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.83 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.83 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.04 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.96 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
7.04 | 3712494 |
MESH:D000236 |
Adenoma |
|
resveratrol |
7.04 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.59 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D000707 |
Anaphylaxis |
|
mangiferin |
5.61 | 16536907 14669257 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.66 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.58 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.58 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
mangiferin |
7.41 | 18450471 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
7.41 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 16609825 19232924 18316065 17507914 17157402 18940202 18775368 18177632 17688650 18558336 18396377 19460635 15238991 18985861 20603192 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.19 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.13 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.25 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.25 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
mangiferin |
5.02 | 9881647 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.44 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.13 | 17651959 17534123 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.72 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.72 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.72 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.75 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.72 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.74 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.55 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
2.83 | 7505956 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.74 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002761 |
Cholangitis |
|
1-Naphthylisothiocyanate |
6.38 | 12912871 |
MESH:D002779 |
Cholestasis |
|
1-Naphthylisothiocyanate |
14.06 | 12927374 15500046 18590720 18164287 7624871 15913567 16629650 19486331 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
14.06 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.06 | 16919318 15861022 17681005 17333356 16105132 11677210 17110522 |
MESH:D002780 |
Cholestasis, Intrahepatic |
|
1-Naphthylisothiocyanate |
6.03 | 10220858 19407337 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.27 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.47 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.82 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.50 | 16575769 17688650 8888407 |
MESH:D003457 |
Cryptosporidiosis |
|
mangiferin |
6.03 | 16547730 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.15 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.94 | 8156756 8970840 11906362 11298694 2524372 12868966 14531868 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.61 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
mangiferin |
9.18 | 19028559 12093613 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
9.18 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
mangiferin |
4.78 | 11315760 9881663 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.78 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
mangiferin |
9.85 | 19706694 19960420 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.85 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-Naphthylisothiocyanate |
15.69 | 7624871 18289764 20133375 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
15.69 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
15.69 | 8291058 6679447 18692083 9328219 9653073 9022650 18289764 11289319 16192314 6482804 7440962 18648102 1440618 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate |
15.69 | 12540782 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.69 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
15.69 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
5.11 | 16935035 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.17 | 1851702 |
MESH:D004487 |
Edema |
|
Furosemide |
12.29 | 11834646 |
MESH:D004487 |
Edema |
|
resveratrol |
12.29 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.29 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.55 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.55 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.99 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.29 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.09 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.99 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.68 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.44 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.22 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.13 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.94 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
mangiferin |
13.94 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.94 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.06 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.26 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.19 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.15 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.93 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
mangiferin |
4.46 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
4.12 | 12660669 16011733 16845234 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006505 |
Hepatitis |
|
1-Naphthylisothiocyanate |
10.06 | 18590720 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
10.06 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 12621046 16120746 |
MESH:D006561 |
Herpes Simplex |
|
mangiferin |
10.78 | 10715843 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
10.78 | 16876885 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.02 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
5.18 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.81 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.11 | 17188708 |
MESH:D006946 |
Hyperinsulinism |
|
mangiferin |
5.09 | 9881663 11315760 |
MESH:D006949 |
Hyperlipidemias |
|
mangiferin |
10.14 | 15975614 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
10.14 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
6.05 | 15086907 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.08 | 15034207 |
MESH:D006967 |
Hypersensitivity |
|
mangiferin |
4.79 | 16536907 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
12.27 | 16612254 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
12.27 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.41 | 17488730 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.81 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
6.05 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.73 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.59 | 15811171 |
MESH:D007154 |
Immune System Diseases |
|
mangiferin |
6.03 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.78 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
mangiferin |
8.83 | 15222974 |
MESH:D007249 |
Inflammation |
|
resveratrol |
8.83 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.83 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.72 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
mangiferin |
4.41 | 11315760 |
MESH:D007511 |
Ischemia |
|
mangiferin |
5.41 | 16806951 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.19 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
7.17 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
mangiferin |
7.17 | 12093613 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.67 | 6582329 |
MESH:D007859 |
Learning Disorders |
|
mangiferin |
5.09 | 19182383 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
mangiferin |
4.69 | 15498116 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.64 | 16087638 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.26 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
1-Naphthylisothiocyanate |
3.21 | 17184895 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
4.70 | 19073162 20405173 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.70 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.95 | 3712494 598648 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.95 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.44 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
mangiferin |
2.76 | 18816296 18520028 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.76 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.42 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.96 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.40 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.18 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.38 | 17992120 |
MESH:D008569 |
Memory Disorders |
|
mangiferin |
5.06 | 19182383 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.49 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.27 | 18765137 18803445 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.54 | 16267019 16490592 17164350 17049120 17935668 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.02 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.14 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.21 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
mangiferin |
6.51 | 17052832 16584858 19172585 16697266 16538859 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
6.51 | 16456233 17125593 17188708 16317513 17015251 16525036 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.31 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.31 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.91 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.80 | 18551238 |
MESH:D009336 |
Necrosis |
|
Caerulein |
11.80 | 15028970 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.51 | 3581430 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.14 | 8985016 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
6.05 | 15086907 |
MESH:D009410 |
Nerve Degeneration |
|
mangiferin |
4.70 | 17433543 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.49 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.49 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.90 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.52 | 17929310 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
6.05 | 17945291 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.23 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.19 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.37 | 17513867 |
MESH:D010195 |
Pancreatitis |
|
Caerulein |
5.90 | 15028970 17948936 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.62 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
mangiferin |
3.74 | 17433543 |
MESH:D010382 |
Peliosis Hepatis |
|
1-Naphthylisothiocyanate |
14.38 | 20133375 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
14.38 | 12520081 |
MESH:D010518 |
Periodontitis |
|
mangiferin |
5.78 | 19026997 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.64 | 6228378 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.81 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
17.21 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.21 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.21 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.62 | 15767336 17804756 16731767 17675339 17718901 17636462 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.71 | 12752131 11422049 |
MESH:D011833 |
Radiation Injuries, Experimental |
|
mangiferin |
6.58 | 15830843 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.76 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
7.30 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
7.30 | 15827377 16314181 17058453 17520802 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.73 | 15912074 16096441 12394941 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.46 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.29 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.19 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.19 | 1511512 11738929 14763951 17978042 3137016 11044598 16876388 15475178 |
MESH:D012772 |
Shock, Septic |
|
mangiferin |
5.39 | 15177305 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
5.88 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.88 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.86 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.71 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.86 | 17052386 |
MESH:D013276 |
Stomach Ulcer |
|
mangiferin |
4.38 | 17918041 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.58 | 16321402 |
MESH:D013921 |
Thrombocytopenia |
|
1-Naphthylisothiocyanate |
4.86 | 20133375 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.97 | 3712494 6587162 7505956 6582329 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.31 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.41 | 17262798 |
MESH:D014235 |
Trichinellosis |
|
mangiferin |
6.23 | 14669257 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.67 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.14 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.14 | 8074119 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.78 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.47 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.20 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.93 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.93 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.44 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |